These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 28155742)

  • 41. The introduction of Haemophilus influenzae B (Hib) vaccine.
    Murphy JF
    Ir Med J; 1992 Dec; 85(4):123. PubMed ID: 1473940
    [No Abstract]   [Full Text] [Related]  

  • 42. Introducing pentavalent vaccine in EPI in India: issues involved.
    John TJ; Muliyil J
    Indian J Med Res; 2010 Oct; 132():450-3; author reply 453-5. PubMed ID: 20966525
    [No Abstract]   [Full Text] [Related]  

  • 43. Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage --- National Immunization Survey, United States, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(33):1069-72. PubMed ID: 20798669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
    Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
    Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].
    Conyn-van Spaendonck MA; Veldhuijzen IK; Suijkerbuijk AW; Hirasing RA
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1069-73. PubMed ID: 10850110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Technical support and the immunization program performance in Côte d'Ivoire].
    Aplogan A; Palenfo D; Mwamba G; Coulibaly Kone AS; Koffi AC
    Sante Publique; 2019; Vol. 31(1):177-186. PubMed ID: 31210512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials.
    Black S
    Expert Rev Vaccines; 2015; 14(12):1543-8. PubMed ID: 26414015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Up-to-date Haemophilus influenzae type b vaccination coverage during a vaccine shortage.
    White KE; Pabst LJ; Cullen KA
    Pediatrics; 2011 Mar; 127(3):e707-12. PubMed ID: 21339271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of the DTwP Haemophilus influenzae b conjugate vaccination in Mexico (1999-2007).
    Gómez de León Cruces P; Díaz García J; Santos JI
    Arch Med Res; 2010 May; 41(4):281-7. PubMed ID: 20637372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Surveillance programmes to evaluate the effectiveness of vaccination programmes using vaccination against Haemophilus influenzae type b and varicella as examples].
    Kalies H; Siedler A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Nov; 52(11):1011-8. PubMed ID: 19760247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lessons learned from the 2007 to 2009 Haemophilus influenzae type B vaccine shortage: implications for future vaccine shortages and public health preparedness.
    Chamberlain AT; Wells K; Seib K; Kudis A; Hannan C; Orenstein WA; Whitney EA; Hinman AR; Buehler JW; Omer SB; Berkelman RL
    J Public Health Manag Pract; 2012; 18(3):E9-E16. PubMed ID: 22473128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction.
    Sigaúque B; Vubil D; Sozinho A; Quintó L; Morais L; Sacoor C; Carvalho MG; Verani JR; Alonso PL; Roca A
    J Pediatr; 2013 Jul; 163(1 Suppl):S19-24. PubMed ID: 23773589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign.
    Trotter CL; Ramsay ME; Slack MP
    Commun Dis Public Health; 2003 Apr; 6(1):55-8. PubMed ID: 12736974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemophilus influenzae infections following licensure of the Hib vaccine.
    Alexander WJ; Shaw JF; Holmes JR
    N Engl J Med; 1987 Jul; 317(3):167-8. PubMed ID: 3496536
    [No Abstract]   [Full Text] [Related]  

  • 55. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
    Eskola J
    J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease.
    Wood N; Menzies R; McIntyre P
    Intern Med J; 2005 Sep; 35(9):530-5. PubMed ID: 16105154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
    Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
    Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of oropharyngeal colonization by Haemophilus influenzae type b in Iranian children.
    Karimi A; Alborzi A; Fahimzad A; Gooya M; Esteghamati A; Armin SH; Fallah F
    East Mediterr Health J; 2009; 15(3):544-8. PubMed ID: 19731770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination.
    Murphy TV; White KE; Pastor P; Gabriel L; Medley F; Granoff DM; Osterholm MT
    JAMA; 1993 Jan; 269(2):246-8. PubMed ID: 8417244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.